North Macedonia vs Taiwan, China: Dealing with construction permits: Quality control during
North Macedonia
2 DB16-20 methodology
in 2019
Taiwan, China
2 DB16-20 methodology
in 2019
North Macedonia rank
20th
Taiwan, China rank
20th
Dealing with construction permits: Quality control during over time
- North Macedonia
- Taiwan, China
How they compare
North Macedonia currently reports 2 DB16-20 methodology against 2 DB16-20 methodology in Taiwan, China, a difference of 0 DB16-20 methodology.
Across all 6 years both countries report, Taiwan, China has been ahead every year.
North Macedonia ranks 20th and Taiwan, China ranks 20th of 185 countries.
Frequently asked questions
- Which has higher dealing with construction permits: quality control during, North Macedonia or Taiwan, China?
- North Macedonia, at 2 DB16-20 methodology against 2 DB16-20 methodology in Taiwan, China as of 2019.
- What is the difference in dealing with construction permits: quality control during between North Macedonia and Taiwan, China?
- 0 DB16-20 methodology, with North Macedonia ahead.
- How many years of comparable data are there for North Macedonia and Taiwan, China?
- 6 years are reported by both, from 2014 to 2019.
- How do North Macedonia and Taiwan, China rank globally for dealing with construction permits: quality control during?
- North Macedonia ranks 20th and Taiwan, China ranks 20th of 185 countries.
- Where does this data come from?
- The World Bank, published as Dealing with construction permits: Quality control during construction index (0-3) (DB16-20 methodology). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The quality control during construction index evaluates quality control during the construction process. It has two components: (i) whether inspections are mandated by law during the construction process; (ii) whether inspections during construction are implemented in practice. The index is computed based on the methodology in the DB16-20 studies.